🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSouth Korea Ozempic availability — 12 month update Page 3

South Korea Ozempic availability — 12 month update

greg_boulder Sat, Aug 16, 2025 at 6:58 AM 40 replies 1,750 viewsPage 3 of 8
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Aug 22, 2025 at 6:21 AM#11
EndoResFellow said:
The version of this that has an answer is narrower than the version being asked.

That holds for the injectable. The oral formulation has different absorption behaviour and the dose numbers are not interchangeable, which is worth saying out loud because people quote them as if they were.

31 6JakeSmashed95, NauseaFreeNow, SteveThurs and 28 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Aug 22, 2025 at 2:00 PM#12
JenPlateau said:
Steady state is the thing most people miss.

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

30 5wanda_boise, NurseAsh_DET, BenResearch_OR and 27 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Aug 22, 2025 at 9:39 PM#13
EndoResFellow said:
The version of this that has an answer is narrower than the version being asked.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

29 4Dr.SleepRoch, laura_annarbor, JenMemphis and 26 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Aug 23, 2025 at 5:18 AM#14

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

28 3PharmHunterJen, TomTeleRx, DoseLogDan and 25 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Aug 23, 2025 at 12:57 PM#15

Moderator note: a couple of off-topic posts removed. No action needed from anybody.

27 2PurityPaulOR, MaxMetOK, MounjBrad and 24 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register